These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22907901)

  • 1. A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.
    Huang X; Chen DY
    ChemMedChem; 2012 Nov; 7(11):1882-94. PubMed ID: 22907901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering effects of ezetimibe and simvastatin in combination.
    Ijioma N; Robinson JG
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe and fenofibrate combination therapy for mixed hyperlipidemia.
    Moon YS; Chun P; Chung S
    Drugs Today (Barc); 2007 Jan; 43(1):35-45. PubMed ID: 17315051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):4. PubMed ID: 22233589
    [No Abstract]   [Full Text] [Related]  

  • 6. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striated muscle safety of ezetimibe/simvastatin (Vytorin).
    Davidson MH; Maccubbin D; Stepanavage M; Strony J; Musliner T
    Am J Cardiol; 2006 Jan; 97(2):223-8. PubMed ID: 16442367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct.
    Mitka M
    JAMA; 2008 Feb; 299(8):885-7. PubMed ID: 18314425
    [No Abstract]   [Full Text] [Related]  

  • 9. Ezetimibe and recent clinical trials: a look on the bright side.
    Ahmed MH
    Expert Opin Drug Saf; 2010 Jul; 9(4):511-4. PubMed ID: 20377476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
    Farnier M
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
    Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
    Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
    Catapano A; Brady WE; King TR; Palmisano J
    Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia].
    Sumarokov AB; Kukharchuk VV
    Ter Arkh; 2014; 86(12):107-15. PubMed ID: 25804051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of ezetimibe/simvastatin versus simvastatin monotherapy on platelet and inflammatory biomarkers in patients with metabolic syndrome.
    Miller M; DiNicolantonio JJ; Can M; Grice R; Damoulakis A; Serebruany VL
    Cardiology; 2013; 125(2):74-7. PubMed ID: 23652826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.
    Agouridis AP; Filippatos TD; Tsimihodimos V; Elisaf MS
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):355-66. PubMed ID: 21438815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy.
    Zinellu A; Sotgia S; Loriga G; Deiana L; Satta AE; Carru C
    Amino Acids; 2012 Oct; 43(4):1499-507. PubMed ID: 22278741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
    Fazio S; Guyton JR; Polis AB; Adewale AJ; Tomassini JE; Ryan NW; Tershakovec AM
    Am J Cardiol; 2010 Feb; 105(4):487-94. PubMed ID: 20152243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapy.
    Robins DN
    J Drugs Dermatol; 2007 Sep; 6(9):946-7. PubMed ID: 17941369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia.
    Kei AA; Filippatos TD; Elisaf MS
    Expert Opin Drug Saf; 2016; 15(4):559-69. PubMed ID: 26898906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.